<DOC>
	<DOC>NCT00556491</DOC>
	<brief_summary>This study proposes to investigate whether treatment with minocycline pre-operatively in patients with mild to moderate chronic kidney disease undergoing cardiac surgery will reduce the occurence of kidney injury.</brief_summary>
	<brief_title>Minocycline to Prevent Acute Kidney Injury After Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Age over 18 years planned CABG or valvular surgery with cardiopulmonary bypass Serum creatinine available (within 30 days) Estimated GFR 1590ml/min using the abbreviated MDRD formula (CKD stages 24) Emergent or urgent surgery (to be performed within the next 36 hours) End stage renal disease, or GFR &lt; 15ml/min (CKD stage 5) Estimated GFR&gt;90ml/min (CKD stage 1 or no CKD) Ongoing infection by positive blood, urine or sputum cultures or pneumonia on CXR Allergy to minocycline or tetracyclines inability to take oral medications use of preoperative vasopressor agents at therapeutic doses Pregnant or lactating females Advanced liver disease by history or exam(cirrhosis, ascitis, jaundice) Rising creatinine meeting the definition of acute kidney injury prior to surgery Neurologic signs or symptoms or history of increased intracranial pressure current participation in another research study involving an investigational drug or device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>renal</keyword>
	<keyword>kidney</keyword>
	<keyword>injury</keyword>
	<keyword>acute</keyword>
	<keyword>bypass</keyword>
	<keyword>cardiac</keyword>
	<keyword>minocycline</keyword>
	<keyword>prevention</keyword>
	<keyword>Acute Kidney Failure</keyword>
</DOC>